QA: ASSEMBLY BIOSCIENCES INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001426800_2023_ASSEMBLY_BIOSCIENCES_INC.pdf

Logs

Graph

Absolute values for 0001426800, ASSEMBLY BIOSCIENCES INC.

  xvar xval
0 AssetsCurrent 96,967,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 743,000
3 remainder_Assets 4,084,000
4 LiabilitiesCurrent 16,296,000
5 LiabilitiesNoncurrent 2,834,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 24,134,000
9 ResearchAndDevelopmentExpense 69,980,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,022,000
13 remainder_ComprehensiveNetIncome -384,000
  yvar yval
0 Assets 101,794,000
1 Liabilities 19,130,000
2 Expenses 94,114,000
3 Revenues 0
4 StockholdersEquity 82,664,000
5 NetIncome -93,092,000
6 ComprehensiveNetIncome -93,284,000
7 BaseVar 108,222,000
8 EconomicCapitalRatio 0.809

Edgar->Model Mapping

Feature Distribution

Change over Time